Concepts (44)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genes, Mitochondrial | 1 | 2025 | 14 | 0.930 |
Why?
|
| Genome, Viral | 2 | 2023 | 119 | 0.840 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 592 | 0.750 |
Why?
|
| Mitochondria | 1 | 2025 | 523 | 0.700 |
Why?
|
| Mutation | 1 | 2021 | 1177 | 0.480 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2025 | 247 | 0.390 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 704 | 0.330 |
Why?
|
| Humans | 11 | 2025 | 43102 | 0.290 |
Why?
|
| Phylogeny | 2 | 2022 | 769 | 0.270 |
Why?
|
| Disease Progression | 2 | 2025 | 667 | 0.230 |
Why?
|
| Hawaii | 2 | 2022 | 2011 | 0.230 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2024 | 31 | 0.220 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2024 | 42 | 0.210 |
Why?
|
| Tuberculosis | 1 | 2024 | 78 | 0.200 |
Why?
|
| Ukraine | 1 | 2023 | 4 | 0.200 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2024 | 109 | 0.200 |
Why?
|
| Russia | 1 | 2023 | 29 | 0.200 |
Why?
|
| Antiviral Agents | 1 | 2025 | 195 | 0.190 |
Why?
|
| Public Policy | 1 | 2022 | 36 | 0.190 |
Why?
|
| Myocardium | 1 | 2024 | 263 | 0.190 |
Why?
|
| Immunity, Innate | 1 | 2023 | 171 | 0.180 |
Why?
|
| Epitopes | 1 | 2022 | 157 | 0.180 |
Why?
|
| Viral Envelope Proteins | 1 | 2022 | 91 | 0.180 |
Why?
|
| Sequence Analysis | 1 | 2021 | 26 | 0.170 |
Why?
|
| Membrane Glycoproteins | 1 | 2022 | 224 | 0.170 |
Why?
|
| Health Policy | 1 | 2022 | 184 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 306 | 0.170 |
Why?
|
| Genomics | 1 | 2022 | 293 | 0.160 |
Why?
|
| Algorithms | 1 | 2022 | 509 | 0.150 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 307 | 0.150 |
Why?
|
| Autopsy | 1 | 2024 | 48 | 0.060 |
Why?
|
| Allergy and Immunology | 1 | 2024 | 14 | 0.050 |
Why?
|
| Virus Diseases | 1 | 2024 | 27 | 0.050 |
Why?
|
| Respiration | 1 | 2024 | 56 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2024 | 206 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 127 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 306 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3156 | 0.030 |
Why?
|
| Aged | 1 | 2024 | 8214 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 12222 | 0.020 |
Why?
|
| Adult | 1 | 2024 | 13872 | 0.020 |
Why?
|
| Animals | 1 | 2024 | 16992 | 0.020 |
Why?
|
| Male | 1 | 2024 | 23409 | 0.010 |
Why?
|
| Female | 1 | 2024 | 24698 | 0.010 |
Why?
|